AABB promotes coverage and reimbursement policies that support patients’ access to blood products, and transfusion services and cellular therapies. The Association educates policymakers, payers, blood centers and providers on the complexities of coding, billing and reimbursement policies, and advocates for improved coverage and reimbursement policies.
AABB Urges CMS to Adopt Payment Policies That Expand Access to CAR T-Cell Therapy
September 13, 2024
Blood Community Urges CMS to Improve Coverage of Prehospital Blood Transfusion
September 11, 2024
AABB Extends Support for Revised CAR T-Cell Therapy, Therapeutic Apheresis Coverage Policies
September 11, 2024